Drug Chatter -- Tracking biopharma stock chatter

Profile for Myriad Genetics, Inc. (MYGN)

« Back to company index

MYGN Chatter Timeline

Stock Ticker for MYGN

Most Active Tweeters for MYGN

UserTweets
@MariaDa18810214 5
@AmericanBanking 4
@noritsunagirota 4
@stocknewsdotcom 3
@rogersro 3

Recent Tweets for MYGN

pennyomegaCRWE @pennyomegaCRWE
FDA OKs $MYGN 's BRACAnalysis CDx as Companion Diagnostic for Lynparza in Metastatic Breast Cancer Patients https://t.co/w1hDATM8px
January 14th 2018, 8:01pm
MarieSm76375904 @MarieSm76375904
White Pine Capital Has Decreased Its Myriad Genetics $MYGN Position https://t.co/zRbyk222nH
January 14th 2018, 11:01am
windham_kathryn @windham_kathryn
Tieton Capital Management Trimmed Its Myriad Genetics $MYGN Holding https://t.co/hFrnVzAJ0X
January 14th 2018, 10:01am
Margare30926081 @Margare30926081
As Myriad Genetics $MYGN Stock Rose, Camber Capital Management Has Decreased Its Position ...
January 14th 2018, 8:01am
noritsunagirota @noritsunagirota
Myriad Genetics, Inc. $MYGN EPS Estimated At $0.24 https://t.co/EFm3u6dqhr
January 14th 2018, 7:01am
noritsunagirota @noritsunagirota
Fisher Asset Management Has Boosted By $2.13 Million Its Myriad Genetics $MYGN Holding https://t.co/yYGyZqZCfA
January 13th 2018, 6:01am
stockmktgenius @stockmktgenius
$MYGN Myriad Genetics, Inc. - C Top stock up 141% from low. Close: 36.05 VolvsAvg: 1.15 Liq: $21M https://t.co/3PaXRdedRG
January 12th 2018, 6:01pm
MarieSm76375904 @MarieSm76375904
Acadian Asset Management Has Boosted Its Holding in Myriad Genetics $MYGN as Shares Rose ...
January 12th 2018, 2:01pm
Briefingcom @Briefingcom
$MYGN: Myriad Genetics receives FDA Approval of BRACAnalysis CDx as Companion diagnostic for Lynparza https://t.co/wnFzmuMTzr
January 12th 2018, 1:01pm
stockboardinc @stockboardinc
$MYGN Myriad Receives FDA Approval of BRACAnalysis CDx® as Companion Diagnostic for Lynparza™ (olaparib... - https://t.co/RK3ksAZNGO
January 12th 2018, 11:01am
livetraderalrt @livetraderalrt
$MYGN 3.7m ago: Myriad Receives FDA Approval of BRACAnalysis CDx® as Companion Diagnostic for Lynparza™ (olaparib)… https://t.co/BM0ajSgoU0
January 12th 2018, 11:01am
GNWLive @GNWLive
Myriad Receives FDA Approval of BRACAnalysis CDx® as Companion Diagnostic for Lynparza™ (olaparib) In $MYGN https://t.co/wQkWSOwaOB
January 12th 2018, 11:01am
rogersro @rogersro
RT @DonnaYoungDC: #FDA OK's expanded use of $AZN's #Lynparza (olaparib tablets) in #breastcancer; also expands use of $MYGN's BRACAnalysis…
January 12th 2018, 10:01am
DonnaYoungDC @DonnaYoungDC
#FDA OK's expanded use of $AZN's #Lynparza (olaparib tablets) in #breastcancer; also expands use of $MYGN's BRACAna… https://t.co/tcJaJ91z2G
January 12th 2018, 10:01am
SEEKINGALPHA_FS @SEEKINGALPHA_FS
FDA OKs AstraZeneca's Lynparza BRCA-mutated breast cancer; shares up 1% https://t.co/6vDHH8qUCL $AZN $MYGN
January 12th 2018, 9:01am
MarketCurrents @MarketCurrents
FDA OKs AstraZeneca's Lynparza BRCA-mutated breast cancer; shares up 1% https://t.co/7wpHpSLT5S $AZN $MYGN
January 12th 2018, 9:01am
AmericanBanking @AmericanBanking
Myriad Genetics, Inc. $MYGN Given Average Rating of “Hold” by Analysts https://t.co/uZaML2Ba92 #stocks
January 12th 2018, 5:01am
MariaDa18810214 @MariaDa18810214
As Myriad Genetics $MYGN Share Value Rose, Contrarius Investment Management LTD Has Decreased Its Position ...
January 11th 2018, 3:01pm
ChartMill @ChartMill
When comparing the yearly performance of all stocks, we notice that $MYGN is one of the better performing stock ...… https://t.co/IQpsNMCN9L
January 11th 2018, 1:01pm
TheMarketsDaily @TheMarketsDaily
Barclays Reiterates “Hold” Rating for Myriad Genetics $MYGN https://t.co/F7BcfLdmaL
January 11th 2018, 12:01pm
ScoutFinAnalyst @ScoutFinAnalyst
$MYGN Snapshot Presentation is now available #earnings https://t.co/h30khVfBCm
January 11th 2018, 3:01am
ZolmaxNews @ZolmaxNews
Myriad Genetics $MYGN Stock Rating Reaffirmed by Barclays https://t.co/rOgrAOoO1S
January 10th 2018, 2:01pm
dispatchtribune @dispatchtribune
Myriad Genetics $MYGN Stock Rating Reaffirmed by Barclays https://t.co/1ACUJCrSSg
January 10th 2018, 2:01pm
fintel_io @fintel_io
Vanguard Group Inc has filed an amended 13G/A, reporting 10.43% ownership in $MYGN - https://t.co/MbDNBGwJM7
January 10th 2018, 10:01am
confcalltran @confcalltran
The Vanguard Group just provided an update on share ownership of Myriad Genetics https://t.co/yCsrmJiG13 $MYGN
January 10th 2018, 10:01am
QLFilings @QLFilings
$MYGN filed Form SC 13G/A with the SEC. Most mentioned words: power, group, vanguard, class, filed
January 10th 2018, 10:01am
StockTexts @StockTexts
$MYGN Myriad Genetics, Inc. SEC Filing: Form SC 13G/A https://t.co/T1uYV6dfnO
January 10th 2018, 10:01am
TheMarketsDaily @TheMarketsDaily
Myriad Genetics $MYGN Earns Daily Media Impact Score of 0.14 https://t.co/MvlULpaquP
January 10th 2018, 2:01am
TranscriptDaily @TranscriptDaily
Myriad Genetics $MYGN Given “Hold” Rating at Barclays https://t.co/N3AO6YcQnf
January 9th 2018, 9:01pm
TedDeCorte @TedDeCorte
Myriad Genetics (MYGN) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow $MYGN https://t.co/8PKgxNTLcW
January 9th 2018, 6:01pm
dispatchtribune @dispatchtribune
Myriad Genetics $MYGN Receives New Coverage from Analysts at BTIG Research https://t.co/hQ3ue1Rkip
January 9th 2018, 7:01am
TranscriptDaily @TranscriptDaily
Myriad Genetics $MYGN Earns Buy Rating from Analysts at BTIG Research https://t.co/V2obK7IqDQ
January 8th 2018, 5:01pm
Datamonitor_ZM @Datamonitor_ZM
$MYGN 2018 product overview https://t.co/8kTJlWc3r7
January 8th 2018, 5:01pm
AmericanBanking @AmericanBanking
Barclays Reiterates Hold Rating for Myriad Genetics $MYGN https://t.co/ouBPgUNroV #stocks
January 8th 2018, 8:01am
ARatings @ARatings
Barclays Sticks to Its Hold Rating for Myriad Genetics $MYGN https://t.co/pqtKgqFq8Y
January 8th 2018, 8:01am
TheMarketsDaily @TheMarketsDaily
Myriad Genetics, Inc. $MYGN Expected to Post Quarterly Sales of $188.75 Million https://t.co/xniqDMdPSz
January 8th 2018, 8:01am
AmericanBanking @AmericanBanking
Zacks: Analysts Expect Myriad Genetics, Inc. $MYGN Will Announce Quarterly Sales of $188.75 Million https://t.co/qGExBPZUSo #stocks
January 8th 2018, 8:01am
WeekHerald @WeekHerald
California State Teachers Retirement System Sells 10,938 Shares of Myriad Genetics, Inc. $MYGN https://t.co/aLtBQoX5Em
January 8th 2018, 4:01am
ledgerzette @ledgerzette
Myriad Genetics $MYGN PT Set at $45.00 by Stephens https://t.co/FpS3LXxJwm
January 7th 2018, 8:01pm
intercooleronli @intercooleronli
Myriad Genetics $MYGN PT Set at $45.00 by Stephens https://t.co/HFI1xsfB2j #investing
January 7th 2018, 8:01pm
OlympiaReport @OlympiaReport
Myriad Genetics $MYGN Research Coverage Started at BTIG Research https://t.co/q6lzCj9fMr
January 7th 2018, 3:01am
WatchlistN @WatchlistN
Stephens Analysts Give Myriad Genetics $MYGN a $45.00 Price Target https://t.co/usutqJFNd1
January 6th 2018, 10:01am
MariaDa18810214 @MariaDa18810214
Myriad Genetics $MYGN Holder S&T Bank Has Lowered Its Holding https://t.co/9fW55cf8i3
January 6th 2018, 5:01am
TribuneTrueBlue @TribuneTrueBlue
Myriad Genetics $MYGN PT Set at $45.00 by Stephens https://t.co/2pRkZIOpOb
January 5th 2018, 1:01pm
firsttomarkets @firsttomarkets
Myriad Genetics Inc. Initiated Coverage by BTIG Research (Ranked 50th) to Buy with $41PT $MYGN #MYGN https://t.co/M0qlMKd466
January 5th 2018, 10:01am
stocknewsdotcom @stocknewsdotcom
$MYGN BTIG Research initiates as a buy, $41PT https://t.co/kKCCo5pwwT
January 5th 2018, 9:01am
AlertTrade @AlertTrade
UPGRADES & DOWNGRADES ? $MYGN: BTIG Research starts at Buy https://t.co/pbXTWnFRGy via ? https://t.co/U5xCBHFNAP
January 5th 2018, 9:01am
Briefingcom @Briefingcom
$MYGN: BTIG Research starts at Buy
January 5th 2018, 9:01am
AmericanBanking @AmericanBanking
Myriad Genetics $MYGN Coverage Initiated at BTIG Research https://t.co/bMUfr1ogFV #stocks
January 5th 2018, 8:01am
MariaDa18810214 @MariaDa18810214
Analysts See $0.24 EPS for Myriad Genetics, Inc. $MYGN https://t.co/7wFeTeEsLL
January 5th 2018, 8:01am

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.